OPKO Health's(NASDAQ:OPK)Rayaldee, which works to increase vitamin D levels,met its primary endpoint based on top-line data from a phase 2 trial of COVID-19 outpatients. By day 7, mean serum vitamin D...
网页链接OPKO Health's(NASDAQ:OPK)Rayaldee, which works to increase vitamin D levels,met its primary endpoint based on top-line data from a phase 2 trial of COVID-19 outpatients. By day 7, mean serum vitamin D...
网页链接
精彩评论